Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Open Access
- 19 August 2016
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 119 (5), 652-665
- https://doi.org/10.1161/circresaha.116.308445
Abstract
Rationale: The diabetes drug metformin is under investigation in cardiovascular disease but the molecular mechanisms underlying possible benefits are poorly understood.Keywords
This publication has 58 references indexed in Scilit:
- Molecular mechanism of action of metformin: old or new insights?Diabetologia, 2013
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic LipogenesisCancer Prevention Research, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Activated AMPK inhibits PPAR-α and PPAR-γ transcriptional activity in hepatoma cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- Novel cross-talk within the IKK family controls innate immunityBiochemical Journal, 2011
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJCI Insight, 2010
- Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart FailureCirculation Research, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Inflammation and metabolic disordersNature, 2006